BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 20173166)

  • 1. Contrast material for abdominal dynamic contrast-enhanced 3D MR angiography with parallel imaging: intraindividual equimolar comparison of a macrocyclic 1.0 M gadolinium chelate and a linear ionic 0.5 M gadolinium chelate.
    Hadizadeh DR; Von Falkenhausen M; Kukuk GM; Schöneseiffen K; Gieseke J; Schild HH; Willinek WA
    AJR Am J Roentgenol; 2010 Mar; 194(3):821-9. PubMed ID: 20173166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time-resolved contrast-enhanced three-dimensional pulmonary MR-angiography: 1.0 M gadobutrol vs. 0.5 M gadopentetate dimeglumine.
    Fink C; Bock M; Kiessling F; Lichy MP; Krissak R; Zuna I; Schmähl A; Delorme S; Kauczor HU
    J Magn Reson Imaging; 2004 Feb; 19(2):202-8. PubMed ID: 14745754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraindividual quantitative and qualitative comparison of gadopentetate dimeglumine and gadobutrol in time-resolved contrast-enhanced 4-dimensional magnetic resonance angiography in minipigs.
    Hadizadeh DR; Jost G; Pietsch H; Weibrecht M; Perkuhn M; Boschewitz JM; Keil VC; Träber F; Kukuk GM; Schild HH; Willinek WA
    Invest Radiol; 2014 Jul; 49(7):457-64. PubMed ID: 24598442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of cerebral metastases on magnetic resonance imaging: intraindividual comparison of gadobutrol with gadopentetate dimeglumine.
    Anzalone N; Gerevini S; Scotti R; Vezzulli P; Picozzi P
    Acta Radiol; 2009 Oct; 50(8):933-40. PubMed ID: 19626475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for MR angiography of peripheral arteries.
    Gerretsen SC; le Maire TF; Miller S; Thurnher SA; Herborn CU; Michaely HJ; Kramer H; Vanzulli A; Vymazal J; Wasser MN; Ballarati CE; Kirchin MA; Pirovano G; Leiner T
    Radiology; 2010 Jun; 255(3):988-1000. PubMed ID: 20501735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraindividual comparison of gadobutrol and gadopentetate dimeglumine for detection of myocardial late enhancement in cardiac MRI.
    De Cobelli F; Esposito A; Perseghin G; Sallemi C; Belloni E; Ravelli S; Lanzani C; Del Maschio A
    AJR Am J Roentgenol; 2012 Apr; 198(4):809-16. PubMed ID: 22451545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal dynamic MRI enhancement patterns of the upper abdominal organs: gadoxetic acid compared with gadobutrol.
    Kühn JP; Hegenscheid K; Siegmund W; Froehlich CP; Hosten N; Puls R
    AJR Am J Roentgenol; 2009 Nov; 193(5):1318-23. PubMed ID: 19843748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraindividual comparison of 1.0 M gadobutrol and 0.5 M gadopentetate dimeglumine for time-resolved contrast-enhanced three-dimensional magnetic resonance angiography of the upper torso.
    Fink C; Puderbach M; Ley S; Risse F; Kuder TA; Bock M; Thaler J; Plathow C; Kauczor HU
    J Magn Reson Imaging; 2005 Aug; 22(2):286-90. PubMed ID: 16028246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadobutrol for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison with gadopentetate dimeglumine.
    Durmus T; Schilling R; Doeblin P; Huppertz A; Hamm B; Taupitz M; Wagner M
    Invest Radiol; 2012 Mar; 47(3):183-8. PubMed ID: 22183078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast-enhanced MR Angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
    Prokop M; Schneider G; Vanzulli A; Goyen M; Ruehm SG; Douek P; Daprà M; Pirovano G; Kirchin MA; Spinazzi A
    Radiology; 2005 Feb; 234(2):399-408. PubMed ID: 15616119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced MR angiography for the diagnosis of intracranial vascular disease: optimal dose of gadopentetate dimeglumine.
    Jung HW; Chang KH; Choi DS; Han MH; Han MC
    AJR Am J Roentgenol; 1995 Nov; 165(5):1251-5. PubMed ID: 7572513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-spatial-resolution lower extremity MR angiography at 3.0 T: contrast agent dose comparison study.
    Habibi R; Krishnam MS; Lohan DG; Barkhordarian F; Jalili M; Saleh RS; Ruehm SG; Finn JP
    Radiology; 2008 Aug; 248(2):680-92. PubMed ID: 18574136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 1.0 M gadobutrol and 0.5 M gadopentetate dimeglumine-enhanced magnetic resonance imaging in five hundred seventy-two patients with known or suspected liver lesions: results of a multicenter, double-blind, interindividual, randomized clinical phase-III trial.
    Hammerstingl R; Adam G; Ayuso JR; Van Beers B; Belfiore G; Bellin MF; Bongartz G; Ernst O; Frericks B; Giuseppetti G; Heinz-Peer G; Laghi A; Martin J; Pering C; Reimer P; Richter GM; Roemer FW; Schäfer FK; Vilgrain V; Vogl TJ; Weishaupt D; Wall A; Zech CJ; Tombach B
    Invest Radiol; 2009 Mar; 44(3):168-76. PubMed ID: 19169143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using a 1 M Gd-chelate (gadobutrol) for total-body three-dimensional MR angiography: preliminary experience.
    Goyen M; Herborn CU; Vogt FM; Kröger K; Verhagen R; Yang F; Bosk S; Debatin JF; Ruehm SG
    J Magn Reson Imaging; 2003 May; 17(5):565-71. PubMed ID: 12720266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose, time-resolved, contrast-enhanced 3D MR angiography in the assessment of the abdominal aorta and its major branches at 3 Tesla.
    Kramer U; Fenchel M; Laub G; Seeger A; Klumpp B; Bretschneider C; Finn JP; Claussen CD; Miller S
    Acad Radiol; 2010 May; 17(5):564-76. PubMed ID: 20171907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic and delayed contrast enhancement in upper abdominal MRI studies: comparison of gadoxetic acid and gadobutrol.
    Zizka J; Klzo L; Ferda J; Mrklovský M; Bukac J
    Eur J Radiol; 2007 May; 62(2):186-91. PubMed ID: 17367974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in injection rates on contrast-enhanced breath-hold three-dimensional MR angiography.
    Kopka L; Vosshenrich R; Rodenwaldt J; Grabbe E
    AJR Am J Roentgenol; 1998 Feb; 170(2):345-8. PubMed ID: 9456943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gadolinium-enhanced three-dimensional MR angiography of the aorta and peripheral arteries: evaluation of a multistation examination using two gadopentetate dimeglumine infusions.
    Earls JP; Patel NH; Smith PA; DeSena S; Meissner MH
    AJR Am J Roentgenol; 1998 Sep; 171(3):599-604. PubMed ID: 9725281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral magnetic resonance angiography with continuous table movement in combination with high spatial and temporal resolution time-resolved MRA With a total single dose (0.1 mmol/kg) of gadobutrol at 3.0 T.
    Voth M; Haneder S; Huck K; Gutfleisch A; Schönberg SO; Michaely HJ
    Invest Radiol; 2009 Sep; 44(9):627-33. PubMed ID: 19652610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla.
    Giesel FL; Mehndiratta A; Risse F; Rius M; Zechmann CM; von Tengg-Kobligk H; Gerigk L; Kauczor HU; Politi M; Essig M; Griffiths PD; Wilkinson ID
    Acta Radiol; 2009 Jun; 50(5):521-30. PubMed ID: 19337867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.